2,751
Views
3
CrossRef citations to date
0
Altmetric
Nephrology

A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain

ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Pages 640-649 | Received 04 Apr 2022, Accepted 03 May 2022, Published online: 19 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Erasmia Sampani, Marieta Theodorakopoulou, Fotini Iatridi & Pantelis Sarafidis. (2023) Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy. Expert Opinion on Pharmacotherapy 24:16, pages 1775-1789.
Read now

Articles from other publishers (2)

Junxing Chay, Jason C. J. Choo & Eric A. Finkelstein. (2024) Cost‐effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore . Nephrology.
Crossref
Anam Zulfiqar, Farhan Zafar, Bushra Yaqub, HassabAlla M. A. Mahmoud, Mohibullah Shah, Einas M. A. Widaa, Haq Nawaz, Naeem Akhtar & Umar Nishan. (2023) Cobalt oxide modified sulfur and phosphorus Co-doped g-C3N4 for screening of urinary human albumin. Microchimica Acta 190:9.
Crossref